First Hawaiian Bank Raises Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

First Hawaiian Bank lifted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 10.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,571 shares of the biopharmaceutical company’s stock after acquiring an additional 530 shares during the period. First Hawaiian Bank’s holdings in […]

Leave a Reply

Your email address will not be published.

Previous post First Hawaiian Bank Buys 505 Shares of Nucor Co. (NYSE:NUE)
Next post First Hawaiian Bank Grows Position in The Kroger Co. (NYSE:KR)